TISSUE MMP-7 EXPRESSION PREDICTS SURVIVAL IN BLADDER CANCER PATIENTS TREATED WITH CISPLATIN-BASED CHEMOTHERAPY

被引:2
|
作者
Szarvas, Tibor
Kramer, Gero
Hess, Jochen
Tschirdewahn, Stephan
Reis, Henning
Romics, Imre
Sevcenco, Sabina
Toetsch, Martin
Ruebben, Herbert
Dorp, Frank Vom
机构
来源
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词
D O I
10.1016/j.juro.2012.02.1867
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
1416
引用
收藏
页码:E575 / E575
页数:1
相关论文
共 50 条
  • [41] Emmprin Expression Predicts Response and Survival following Cisplatin Containing Chemotherapy for Bladder Cancer: A Validation Study
    Hemdan, Tammer
    Malmstrom, Per-Uno
    Jahnson, Staffan
    Segersten, Ulrika
    JOURNAL OF UROLOGY, 2015, 194 (06): : 1575 - 1581
  • [42] Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy
    Argiris, A
    Li, Y
    Murphy, BA
    Langer, CJ
    Forastiere, AA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) : 262 - 268
  • [43] Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy
    Bellmunt, J.
    Paz-Ares, L.
    Cuello, M.
    Cecere, F. L.
    Albiol, S.
    Guillem, V.
    Gallardo, E.
    Carles, J.
    Mendez, P.
    de la Cruz, J. J.
    Taron, M.
    Rosell, R.
    Baselga, J.
    ANNALS OF ONCOLOGY, 2007, 18 (03) : 522 - 528
  • [44] Clinical outcomes following neoadjuvant cisplatin-based chemotherapy for bladder cancer in elderly compared with younger patients
    Chau, C.
    Wheater, M.
    Geldart, T.
    Crabb, S. J.
    EUROPEAN JOURNAL OF CANCER CARE, 2015, 24 (02) : 155 - 162
  • [45] CARBOPLATIN, METHOTREXATE, AND VINBLASTINE IN PATIENTS WITH BLADDER-CANCER WHO WERE INELIGIBLE FOR CISPLATIN-BASED CHEMOTHERAPY
    BELLMUNT, J
    ALBANELL, J
    GALLEGO, OS
    RIBAS, A
    VICENTE, P
    CARULLA, J
    DETORRES, J
    MOROTE, J
    LOPEZ, M
    SOLE, LA
    CANCER, 1992, 70 (07) : 1974 - 1979
  • [46] Influence of Creatinine Clearance on Survival Parameters in Small Cell Lung Cancer Treated with Cisplatin-Based Chemotherapy Regimen
    Gozel, Sedat
    Sumbul, Ahmet
    Sedef, Ali Murat
    Besen, Ayberk
    Mertsoylu, Huseyin
    Batmaci, Celal
    Kose, Fatih
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S701 - S702
  • [47] YRNA expression predicts survival in bladder cancer patients
    Tolkach, Yuri
    Stahl, Anna Franziska
    Niehoff, Eva-Maria
    Zhao, Chenming
    Kristiansen, Glen
    Mueller, Stefan Cajetan
    Ellinger, Joerg
    BMC CANCER, 2017, 17
  • [48] YRNA expression predicts survival in bladder cancer patients
    Yuri Tolkach
    Anna Franziska Stahl
    Eva-Maria Niehoff
    Chenming Zhao
    Glen Kristiansen
    Stefan Cajetan Müller
    Jörg Ellinger
    BMC Cancer, 17
  • [49] LONG-TERM SURVIVAL OF PATIENTS WITH ADVANCED OVARIAN-CARCINOMA TREATED WITH CISPLATIN-BASED CHEMOTHERAPY REGIMENS
    DEPREE, N
    WILS, J
    ANTICANCER RESEARCH, 1989, 9 (06) : 1869 - 1871
  • [50] Prognostic model to predict survival in patients with metastatic upper tract urothelial carcinoma treated with cisplatin-based chemotherapy
    Hsieh, Meng-Che
    Su, Yu-Li
    Chiang, Po-Hui
    Rau, Kun-Ming
    Chen, Yen-Yang
    Huang, Cheng-Hua
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (05) : 385 - 389